Skip to main content

06-07-2018 | Prostate cancer | Editorial | Article

Bipolar androgen therapy: Progress and future directions

Michael Schweizer
Dr Michael Schweizer (University of Washington, Seattle, USA) discusses the potential of a new therapy utilizing the seemingly paradoxical approach of both androgen deprivation and administration, which may potentially have benefit for metastatic prostate cancer patients.

Please log in to get access to this content

Related topics

More on this topic

image credits